pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

MAHA movement faces uncertain future after midterm losses

Nov 4, 2026·read at STAT ↗Negative

Midterm elections swept many of the Make America Healthy Again (MAHA) coalition’s allies out of office, leaving the group led by health secretary Robert F. Kennedy Jr. with a reduced political base.

The movement had already been splintering over issues such as pesticide regulation and had little influence in key races before the vote.

A wave of newly elected Democratic senators, representatives and governors oppose many of MAHA’s policy positions, adding further obstacles for the coalition.

The article interprets the results as a broader rejection of the Trump administration’s health agenda, casting doubt on the coalition’s next steps.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Where does MAHA go from here? 3 possible futures”

read at STAT ↗
467 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
FATE THERAPEUTICS INC
topics
Vaccines

related stories

  • 6d agoSTAT+: Kennedy’s closing arguments for the 2026 midterms: Fraud, vaccines, and MAHASTAT
  • Aug 21Capricor investor calls for change as company awaits decision on Duchenne candidateBioSpace
  • Aug 21Scientists deploy Merck’s Ebola vaccine in DRCSTAT
  • Aug 14Capricor soars on potential FDA review extension, filing amendmentsBioSpace
  • Jul 30Key Senate panel backs Trump’s picks for CDC, pandemic preparednessSTAT